CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was founded in 2017 and is based in Houston, Texas. Show More...
-
Website http://www.cnspharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.03 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.47 -0.28 -0.34 Dividends USD Payout Ratio % * Shares Mil 16.0 14.0 16.0 Book Value Per Share * USD 0.36 Free Cash Flow Per Share * USD -0.08 Return on Assets % -90.22 -90.7 Financial Leverage (Average) 1.04 1.06 Return on Equity % -109.96 -95.89 Return on Invested Capital % -108.71 -95.42 Interest Coverage -157.29 -86.65 -201.49 Current Ratio 0.48 25.38 18.42 Quick Ratio 0.23 23.28 16.01 Debt/Equity